top of page

Related News

NCL statement on FDA review of the oral toxicity of cannabidiol (CBD)

Researchers from the Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, Food and Drug Administration (FDA) recently published an analysis on the toxicity of cannabidiol (CBD).

NCL Chief Executive Officer, Sally Greenberg, said, "These findings unfortunately further validate our concerns around the risks, including negative drug-drug interactions, disruption of critical metabolic pathways, liver injury, reproductive toxicity, and more.”

Read the full statement here.

Recent Posts

How much do you think you know about cannabis? Most people don’t know the truth about the cannabis market, the breadth of products, and their potential side effects. Test your knowledge with the Canna

bottom of page